Sign Up to Receive Your Personalised Learning Resources
Start Learning
The future of dermatology: 4 predictions for 2025
Journal spotlight: Recent literature highlights
Pooled phase III data reinforce dupilumab’s efficacy in H1-antihistamine refractory chronic spontaneous urticaria
FDA approval of nemolizumab gives new treatment option for prurigo nodularis
Supporting healing in epidermolysis bullosa: Innovations and new directions for care
Navigating treatment choices in high-risk early-stage melanoma
Baricitinib 4 mg delivers rapid, significant hair growth in adolescents with severe alopecia areata
From Clinic to CNN: Dr. Shari Lipner’s Journey in Advancing Nail Disorders and Mentoring Future Leaders
Treating moderate-to-severe atopic dermatitis in children and adolescents: Insights from the experts
Dr Ben Kaffenberger joins Expert Faculty: Specialist in complex skin conditions
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Baricitinib 4 mg delivers rapid, significant hair growth in adolescents with severe alopecia areata
View
BEACON study: Initial findings indicate briquilimab provides rapid and effective relief in chronic spontaneous urticaria
View
Honouring Prof. Marcus Maurer
View
Navigating treatment choices in high-risk early-stage melanoma
View
Pooled phase III data reinforce dupilumab’s efficacy in H1-antihistamine refractory chronic spontaneous urticaria
View
Greatest Hits of 2024
View
Rare disease round-up: Pyoderma gangrenosum
View
New data in oral lichen planus shows LP-310 oral tacrolimus reduces pain, ulceration and inflammation
View
ADVENT symposia 2024: Updates in AD, PN and CSU
View
Advances in the treatment of CSU
View
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
